Sep. 10 at 8:48 PM
$HRTX My Take
Posts for or against won’t change the reality for a biotech like Heron Therapeutics. this isn’t a meme stock:). The outcome will be decided by the company’s execution.
I recently took a position (already down ~7%), but I invested because of what I’ve seen: consistent YoY growth, 50% gross margin improvement(that's a big deal), and Heron being right on the edge of profitability. I strongly believe their strategy is to fund company’s expenses, including pipeline development with profits, which could be outstanding.
So why the recent dip while market cap is just ~
$200M? Timing in stocks is never exact, and Q2 results were merely okay, prompting some investors to exit. But management has stated the second half should be much stronger and make up for the first.
Conclusion: If management delivers, I believe the stock could rise significantly, and my conviction is that they will.
If they will not?(low probability i believe), I'm going to do some house cleaning 😁
